$23.05
-1.52[-6.19%]
At close: May 22
$23.05
0[0.00%]
After Hours: 4:00PM EDT
Dianthus Therapeutics
(NASDAQ:DNTH)Dianthus Therapeutics Stock (NASDAQ:DNTH), Quotes and News Summary
Dianthus Therapeutics Stock (NASDAQ: DNTH) stock price, news, charts, stock research, profile.
| Open | $24.670 |
| Close | $23.050 |
| Volume / Avg. | 79.480K / 158.026K |
| Day Range | 23.010 - 25.010 |
| 52 Wk Range | 6.580 - 33.770 |
| Market Cap | $676.505M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 43 |
| Short Interest | 10.3% |
| Days to Cover | 12.71 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Dianthus Therapeutics (DNTH) stock?
You can purchase shares of Dianthus Therapeutics (NASDAQ: DNTH) through any online brokerage.
Who are Dianthus Therapeutics's (DNTH) competitors?
Other companies in Dianthus Therapeutics’s space includes: Cogent Biosciences (NASDAQ:COGT), Sage Therapeutics (NASDAQ:SAGE), CareDx (NASDAQ:CDNA), Pharming (NASDAQ:PHAR) and Tango Therapeutics (NASDAQ:TNGX).
What is the target price for Dianthus Therapeutics (DNTH) stock?
The latest price target for Dianthus Therapeutics (NASDAQ: DNTH) was reported by HC Wainwright & Co. on Thursday, May 16, 2024. The analyst firm set a price target for 40.00 expecting DNTH to rise to within 12 months (a possible 73.54% upside). 10 analyst firms have reported ratings in the last year.
Current Stock Price for Dianthus Therapeutics (DNTH)?
The stock price for Dianthus Therapeutics (NASDAQ: DNTH) is $23.05 last updated May 22, 2024 at 4:00 PM EDT.
Does Dianthus Therapeutics (DNTH) pay a dividend?
There are no upcoming dividends for Dianthus Therapeutics.
When is Dianthus Therapeutics (NASDAQ:DNTH) reporting earnings?
Dianthus Therapeutics’s Q2 earnings are confirmed for Saturday, August 3, 2024.
Is Dianthus Therapeutics (DNTH) going to split?
There is no upcoming split for Dianthus Therapeutics.
What sector and industry does Dianthus Therapeutics (DNTH) operate in?
Dianthus Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.